内蒙古中医药
內矇古中醫藥
내몽고중의약
INNER MONGOL JOURNAL OF TRADITIONAL CHINESE MEDICINE
2009年
11期
15
,共1页
莫西沙星%下呼吸道感染%临床疗效%细菌清除率
莫西沙星%下呼吸道感染%臨床療效%細菌清除率
막서사성%하호흡도감염%림상료효%세균청제솔
Moxifloxacin%Lower respiratory tract infection%Clinic curative effect%bacterium clearance
目的:观察莫西沙星(拜复乐)治疗下呼吸道感染的疗效.方法:将60例下呼吸道感染患者随机分为2组,治疗组予静脉点滴莫西沙量0.4g、1次/日,治疗5～7天.对照组予静脉点滴头孢哌酮舒巴坦2.0g、2次/日,治疗7～10天.观察临床指标,细菌学清除率,临床疗效及安全性.结果:治疗组与对照的有效率分别为93.3%,90%;细菌清除率89.5%,86.1%;两者无显著差异.结论:莫西沙星在治疗下呼吸道感染中疗效确切,使用安全.
目的:觀察莫西沙星(拜複樂)治療下呼吸道感染的療效.方法:將60例下呼吸道感染患者隨機分為2組,治療組予靜脈點滴莫西沙量0.4g、1次/日,治療5～7天.對照組予靜脈點滴頭孢哌酮舒巴坦2.0g、2次/日,治療7～10天.觀察臨床指標,細菌學清除率,臨床療效及安全性.結果:治療組與對照的有效率分彆為93.3%,90%;細菌清除率89.5%,86.1%;兩者無顯著差異.結論:莫西沙星在治療下呼吸道感染中療效確切,使用安全.
목적:관찰막서사성(배복악)치료하호흡도감염적료효.방법:장60례하호흡도감염환자수궤분위2조,치료조여정맥점적막서사량0.4g、1차/일,치료5～7천.대조조여정맥점적두포고동서파탄2.0g、2차/일,치료7～10천.관찰림상지표,세균학청제솔,림상료효급안전성.결과:치료조여대조적유효솔분별위93.3%,90%;세균청제솔89.5%,86.1%;량자무현저차이.결론:막서사성재치료하호흡도감염중료효학절,사용안전.
Objective:To observe the curative effect of moxifloxacin on lower respiratory tract infection.Methods:The 60 patients with lower respiratory tract infection were randomly divided into target and control group,In control group,moxifloxacin injection was added,0.4g,one time every day,course of treatment was 5-7d;and target group,Cefoperazone-Sulbaltam injection was added,2.0g,twice every day,course of treatment was 7-10d.then,dinic index,bacterium clearance、curative effect and safety were observed.Result:They have no obvious difference.Conclusion:Moxifloxacin injection have a good curative effect and safety on lower respiratory tract infection.
